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BACKGROUND: The Muir–Torre syndrome (MTS), a
variant of Lynch syndrome (LS), is characterized by the
presence of sebaceous skin adenomas and/or carcinomas
and keratoacanthomas associated with visceral malig-
nancies. Fordyce granules (FGs) are oral mucosal lesions
previously found in association with LS. The aim of this
study was to analyze the specific frequency of FGs in
sporadic individuals and gene carriers patients with MTS
of known mismatch repair genes mutations. The second-
ary aim was to characterize FGs by means of reflectance
confocal microscopy (RCM).
METHODS: A total of 13 patients belonging to nine
different genetically unrelated MTS kindreds (MLH1 gene
mutation n = 2; MSH2 gene mutation n = 11) and 140
genetically unrelated healthy controls were examined.
Depending on the clinical examination of the oral mucosa
surface, subjects were categorized as either FGs positive
or FGs negative.
RESULTS: FGs were diagnosed in 13 of 13 (100%) of MMR
gene carriers patients with MTS vs. 9 of 140 (6.4%)
controls. The most common site for FGs in MTS was the
vestibular oral mucosa, compared with the gingival
mandibular and retromandibular pad in controls. RCM
examination found multiple sebaceous acinar cells that
appear as round or oval hyper-refractive globules and
that create a lobular aspects of the sebaceous glands
defined as ‘moruliform’ or ‘berry-like’ structures.
CONCLUSIONS: Clinical and RCM evidences of our
study suggest that an activation of the sebaceous glands
system occurs in patients with MTS. Fordyce granules
and intra-oral sebaceous hyperplasia may constitute an
additional clinical parameter, which may be adopted to
distinguish individuals with highest likelihood of being
affected from MTS.
J Oral Pathol Med (2015) 44: 552–557
Keywords: Fordyce granules; lynch syndrome; mismatch repair
genes; Muir–Torre syndrome
Introduction
LS is characterized by the onset of visceral, mainly
colorectal cancer (CRC), at an early age, and high frequency
of synchronous and metachronous colonic and extracolonic
tumors (gastrointestinal, endometrial, ovarian, pancreatic
tumors, transitional cell carcinoma of the ureter and renal
pelvis, and many more) (1, 2). MTS, a variant of LS, is
characterized by the presence of sebaceous skin adenomas
and/or carcinomas and keratoacanthomas associated with
visceral malignancies (3). Sebaceous adenoma is composed
of sebaceous lobules of various sizes that are incompletely
differentiated, and contains basaloid cells at the periphery
and mature sebaceous elements in the center. Sebaceous
carcinoma is a malignant neoplasm with prominent cellular
pleomorphism and anaplasia which most commonly occurs
on the eyelids, where it generally arises from the meibomian
glands or from the Zeiss glands (4, 5). Nearly half of
patients with MTS had two or more visceral malignant
diseases, 10% had more than four, and one individual had
up to nine visceral cancers (6, 7).
FGs are oral mucosal lesions typically found in
association with LS (8). The prevalence of FGs increases
from childhood (0.2%) (9) to adulthood (0.97%) and is
slightly higher in adult males (1.77%) than females (0.52%)
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(10). De Felice et al. (8) reported that an activation of the
sebaceous gland system may occur in individuals carrying
HNPCC gene mutations and/or patients fulﬁlling Amster-
dam criteria. The authors stated that the frequency of
recognizable FGs was approximately 50–90 times higher in
HNPCC patients than in controls and suggested that this
ﬁnding may help clinicians identify affected families (8).
FGs consist in intra-oral ectopic sebaceous glands and are
considered benign lesions arising on the oral mucosa of
adult subjects (Fig. 1). They can be found in different sites
in the oral cavity, mainly at the upper lip vermilion,
retromolar area, and buccal mucosa, and they are clinically
characterized by minuscule yellowish macules or papules,
the size of a pinhead. The clinical examination alone is
enough to easily diagnose FGs, with no need for histopath-
ological examination (11).
FGs should be differentiated from sebaceous glands
hyperplasia (SGH) following the criteria proposed by Daley
(1992) (8); histologically, more than 15 well-differentiated
sebaceous lobules per gland suggest SGHs, while fewer
than 15 lobules are interpreted as FGs.
Further research on larger populations is needed to
conﬁrm the reported clinical association and to prove the
predictive value of FGs in detecting HNPCC and/or in MTS
disorders; in particular, sebaceous skin neoplasms are the
most distinctive features in MTS, and we can therefore
hypothesize that similar to the skin, also the oral mucosa
could exhibit an activation of the sebaceous gland system.
Nowadays, skin can be investigated and characterized
through reﬂectance confocal microscopy (RCM), a non-
invasive diagnostic tool that allows the evaluation of skin
structures at a cellular resolution, constituting a biopsy
‘in vivo.’ While many studies exist on healthy skin and
melanocytic and non-melanocytic lesions, very few studies
have been performed on the characterization of mucosal
lesions (12, 13). This is now possible thanks to the
Vivascope 3000 (Vivascope 3000, Caliber I.D., Roches-
ter, NY, USA). The instrument consists of a handheld probe
that could be directly applied on the area of interest enabling
high-resolution morphology evaluation of cells and struc-
tures in a fast and non-invasive procedure (14).
The aim of this study was to analyze the speciﬁc
frequency of FGs in sporadic individuals and patients gene
carriers of known MMR gene mutations with MTS
phenotype. Moreover, the authors aimed to characterize
intra-oral sebaceous glands by means of reﬂectance confocal
microscopy (RCM) in patients with MTS and sporadic
individuals.
Methods
Population
Inclusion criteria for patients with MTS were as follows:
diagnosis of at least one sebaceous skin neoplasm synchro-
nous or metachronous with at least one internal malignancy
typical of LS; only patients with MTS who agreed to
undergo MMR genetic testing, or for which the MMR germ
line mutational status was already known were enrolled (11
MSH2 and 2 MLH1 germ line mutations; Table 2).
Individuals with undetermined MMR mutational status
were excluded.
The healthy control group included consecutive patients
of both genders, Caucasian race, age ≥ 18 years, who
referred to dental outpatient clinic for the ﬁrst time and
exclusively for dental disease (tooth extraction, caries,
periodontal disease), with no detectable oral mucosal lesions
and no personal or family history of sebaceous skin tumors
or internal malignancies.
A B C D
Figure 1 Clinical and reﬂectance confocal microscopy features of Fordyce granules in patients with Muir–Torre syndrome. (A) Clinical and RCM
appearance of the oral vestibular mucosa in a healthy control subject, (B, C, D) Fordyce granules (FGs) and their RCM patterns in the oral vestibular mucosa
of patient with MTS carrying the MMR germ line mutations. FGs appear as rice-like yellow-white papules surrounded by normal mucosa.
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One hundred forty healthy individuals (64 females and 76
males) with a mean age of 55.01  21.9 years (CI: 51.3–
58.7) and 13 gene carriers patients with MTS of MMR
constitutional mutations (7 females and 6 males) of nine
different genetically unrelated MTS kindreds (Tables 1 and
2) were included in the study; exhaustive clinical and
anamnestic data were collected for each patient, while
signed written informed consent was provided. Veriﬁcation
of cancer occurrence among family members was obtained
in the majority of patients through clinical charts, pathologic
records, or death certiﬁcates.
The oral mucosa surface was examined by two experi-
enced odontostomatologists (Prof. Luca Giannetti and Dr.
Annamaria Pollio) who classiﬁed as either FGs positive or
FGs negative.
Immunohistochemistry
Immunohistochemical analysis of MLH1, MSH2, and
MSH6 proteins was carried out on parafﬁn-embedded
tumor samples. Immunoperoxidase staining using diam-
inobenzidine as a chromogen was run with the NEX-ES
Automatic Staining System (Ventana, Strasbourg, France).
The mouse monoclonal antibodies used were anti-MSH6
(clone 44; Transduction Laboratories) at 1:2000 dilution,
anti-MLH1 (G168-15; Pharmingen) at 1:40 dilution, and
anti-MSH2 (G129-1129; Pharmingen) at 1:40 dilution.
Nuclei were counterstained with hematoxylin. Adjacent
normal tissues from each sample served as positive controls.
Mismatch repair genes mutational analysis
Germ line mutations in hMLH1, hMSH2, and hMSH6 were
studied by single-strand conformation polymorphism
(SSCP) on DNA derived from blood leukocytes. Samples
that showed an altered SSCP mobility pattern were
sequenced by means of the Sequenase PCR product
sequencing kit (Amersham Life Science, Buckinghamshire,
UK) using a Beckman sequencer (model CEQ 8000). The
exons of the MLH1 and MSH2/MSH6 genes from genomic
DNA were individually ampliﬁed and subsequently
sequenced directly. Germ line mutations in MMR genes
were deﬁned according to standard nomenclature recom-
mendations (http://www.hgvs.org/mutnomen/).
The study was approved by the local ethics committee in
accordance with ethical standards on human experimenta-
tion and with the Declaration of Helsinki.
Reﬂectance confocal microscopy (RCM)
Dermoscopic images were recorded by means of a digital
epiluminescence microscope (Vidix, MediciMedical, Cast-
elfranco Emilia, Italy), using 20-fold, 30-fold, and a 50-fold
magniﬁcation. Confocal imaging was collected using a
handheld confocal laser scanning microscope (RCM) (Vi-
vascope 3000, Caliber, Rochester, NY, USA), a non-
invasive diagnostic tool that allows the real time examina-
tion of structures thanks to a diode laser at 830 nm and a
power of <16 mW. RCM provides a horizontal optical
resolution of 1.25 lm and a vertical optical resolution of
5 lm at the center of the ﬁeld of view, acquiring single
frames of 750 9 750 lm at a resolution of 1000 9 1000
pixels. A sequence of full-resolution individual images at a
given depth was acquired for each lesion.
Results
FGs were diagnosed in 13 of 13 (100%) MMR gene carriers
patients with MTS vs. 9 of 140 (6.4%) controls. The
diameter of FGs ranged from 0.5 to 4 mm and the most
common site for FGs being the vestibular oral mucosa in
patients with MTS compared with the gingival and
mandibular retromandibular pad in controls.
In the healthy control group of 140 patients (64 female
and 76 male) with a mean age of 55.01  21.9 years (CI:
51.3–58.7), only 9 (6.4%) patients showed the presence of
FGs localized in oral mucosa at clinical examination.
In patients with MTS, skin lesions were often multiple,
synchronous, or metachronous, and were located predom-
inantly in the head and neck. In this group, there were 23
skin lesions, including 22 sebaceous adenomas and 1
sebaceous carcinomas. The average age at onset of the ﬁrst
skin malignancy was 42.54 years (range 23–65 years). In
eight patients with MTS, sebaceous lesions occurred as the
ﬁrst neoplasm while in the remaining ﬁve patients, these
lesions developed after an internal malignancy. Among the
13 MTS probands, 7 colorectal carcinomas and 2 uterus
carcinomas were found. The average age at onset of the ﬁrst
visceral malignancy was 45.71 years. In addition to skin
and visceral malignancies, the tumor spectrum included one
kidney carcinoma, one carcinoma of the renal pelvis, and
one breast tumor.
RCM features
In reﬂectance confocal microscopy, the superﬁcial layer of
the epidermis of patients and healthy individuals (controls
and with FGs) presents large cells with bright cytoplasm and
small dark nuclei. Those cells appear hyporefractive because
of the glycogen content and well demarcated because of the
desmosomes. Although the superﬁcial layer appears very
similar in patients and controls, in the suprabasal layer of the
epidermis, important differences can be found.
Table 1 Prevalence of Fordyce granules and neoplastic comorbidities in
patients with Muir–Torre syndrome and healthy controls matched for age
and sex
Patients
with
Muir–Torre
Healthy
control
group
P value
(Fisher’s exact
test) a < 0.05
Patients (N%) 13 (100%) 140 (100%)
Age 42.5  11.5
(CI 35.6–49.5)
55.01  21.9
(CI 51.3–58.7)
F/M 7/6 64/76
Patients with
Fordyce
granules (N%)
13 (100%) 9 (6.4%) P < 0.0001
Tumors in patients
Breast 1 (7.7%) 1 (0.7%) P = 0.16
Colon 7 (53.8%) 0 (0%) P < 0.0001
Uterus 2 (15.4%) 0 (0%) P = 0.007
Kidney 1 (7.7%) 0 (0%) P = 0.08
Prostate 1 (7.7%) 1 (0.7%) P = 0.16
Brain 0 (0%) 1 (0.7%) P = 1
Sebaceous
adenoma or
carcinoma
of skin
8 (61.5%) 0 (0%) P < 0.0001
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RCM images of subjects without FGs show the presence
of small bright cells that create a sort of ‘snowﬂake-like’
pattern (Fig. 1a) while the suprabasal layer of the epidermis
of a patient with FGs is characterized by the same rise-like
pattern with the presence of bright lobular structures
representing ectopic sebaceous glands, better seen in the
deepest part of the oral mucosa (Fig. 1b,c).
At the dermoepidermal junction (DEJ), MTS patients
with FGs have dark round dermal papillae with central
bright linear or dotted vessels. In this context, we have
found multiple sebaceous acinar cells that appear as round
or oval hyper-refractive globules that create lobular aspects
of the sebaceous glands deﬁned as ‘moruliform (berry-like)
structures’ (Fig. 1b,c).
On the other hand, the RCM analysis of individuals
without FGs at DEJ shows only the presence of dark dermal
papillae with central vessels and the absence of moruliform
or berry-like structures typically seen in the ectopic
sebaceous glands. In the superﬁcial dermis of healthy
subjects, it is possible to recognize bright hyper-reﬂective
collagen ﬁbers organized in bundles and linear or hairpin
vessels that appear as hyper-refractive tubular structures
(Fig. 1a). In MTS patients with FGs, RCM examination
displays bright collagen ﬁbers, canalicular vessels, and also
moruliform or berry-like structures corresponding to multi-
ple sebaceous glands located in depth.
In case of sebaceous hyperplasia, detected in association
with FGs in one-third of MTS probands, the numbers of the
gland’s lobules at the DEJ increase (Table 2); the lobules
are well demarcated and hyper-refractive and become more
visible not only at the DEJ, but also in most superﬁcial
epidermal layer (Fig. 1d).
Discussion
The main clinical evidences of our study establish an
important connection between FGs and gene carriers
patients with MTS of known MMR gene mutations. Our
study reveals a FGs frequency rate of 100%, which is even
higher than the rate of 86.7% reported in LS by the previous
study that inspired our epidemiological investigation (8). In
addition to research and evaluation of FGs in the cohort of
patients with MTS, we evaluated their frequency in a control
population, reporting an incidence of 6.4%. FGs are
sufﬁciently uncommon in the general population to consider
them as potential markers of MTS. The MTS is, in fact, a
clinical variant of the LS; the two entities share the same
biomolecular pathogenesis, due to constitutional mutations
of MMR genes (15). The main difference concerns the
neoplastic phenotype, which includes in MTS cutaneous
sebaceous neoplasms. The MTS may therefore be consid-
ered as the full phenotypic expression of LS; however, the
reason for an increased susceptibility to the development of
sebaceous neoplasms in certain families is not yet known,
due to the lack of a speciﬁc genotype–phenotype correla-
tion. Our hypothesis supporting the clinical role of FGs
within MTS, as it is in LS, could be conﬁrmed by the
knowledge that, in this setting, skin appendages, and in
particular sebaceous glands, typically tend to both hyper-
plastic and/or clearly neoplastic transformation (sebaceous
adenomas and carcinomas) (16).
Our evidences suggest that FGs are not extremely
common in the general population; moreover, we believe
that from a qualitative point of view, clinical pictures of
sebaceous glands hyperplasia and/or multiplicity of ectopic
glands can be signiﬁcantly associated with the MTS
phenotype.
From a clinical perspective, it is important to collect more
elements to identify whether patients who present with
sebaceous tumors are in need of further biomolecular and
immunohistochemical evaluation. At this regard, a clinical
scoring system has been recently proposed to recognize
which patients with sebaceous neoplasms can be at risk for
MTS, including clinical-anamnestic variables: in particular,
onset age of sebaceous neoplasms, total number of
sebaceous neoplasms, personal and/or family history of
LS-related malignancies (17). We believe that the search for
FGs may constitute an additional clinical parameter, which
should certainly be conﬁrmed in a wide MTS patient cohort,
but which will be adopted as a novel variable to recognize
individuals with the highest likelihood of having MTS.
Daley’s criteria deﬁned the difference between FGs and
mucosal sebaceous hyperplasia, adopting a minimum cutoff
of 15 lobules (11); however, an important limit consists in
the need for histopathology, so that a biopsy of the lesion is
necessary but not always clinically justiﬁed. These criteria
could be improved by including RCM characterization;
in vivo RCM examination may allow diagnostic differentia-
tion between ectopic and hyperplastic glands just based on the
quantitative evaluation of the different components of gland
lobules. It is clear that the RCM approach would avoid the
issue of a histology-based diagnostic deﬁnition for lesions
that do not usually require biopsy and/or surgical excision.
To date, there are no other studies regarding the
diagnostic characterization of mucosal sebaceous glands
by RCM: our innovative approach has shown that it is
possible to deﬁne a characteristic image pattern of ectopic
sebaceous glands of the oral mucosa that partially overlaps
with those of the skin (18). In particular, the snowﬂakes
texture of the mucosal surface, expression of nucleated
keratinocytes, characterizes the entire ﬁeld in which we
distinguish some groups of acinar structures with moruli-
form or berry-like appearance; those are clearly visible also
in the deeper dermal layers, probably due to the absence of
the superﬁcial keratinized layer. In fact, it is known that the
mucous membranes in the superﬁcial layer show large ill-
demarcated cells with prominent nucleus, while the supra-
basal layers show large cells with small nucleus, which are
hyporefractive (because of the glycogen content) and well
demarcated (because of desmosomes).
It is important to underline that a few sebaceous structures
can be visible in both healthy and FGs mucosa; those appear
as small hyper-refractive cell clusters and become therefore
better visible while the gland becomes ectopic and, at the
same time, more superﬁcial. This can be due to a sort of
progression from single sebaceous cells, to glandular
ectopy, to hyperplasia (Fig. 1).
There are therefore evidences in favor of a link between
ectopic sebaceous gland and MMR genes’ defects. The
biological signiﬁcance of this association remains, to date,
unclear. Hedgehog signaling pathway has been shown to
increase the size and number of sebaceous glands (19, 20);
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the authors of this study suggest that the activation of Hh
pathway may coexist in HNPCC/MTS, leading to develop-
ment of FGs. In the end, we hypothesize that the activation
of the sebaceous glands’ system occurs in patients with
MTS. This hypothesis is supported by the immunohisto-
chemical and molecular characterization that allowed us to
conﬁrm the molecular pathogenesis in all patients with MTS
enrolled in the study. All patients carried speciﬁc MMR
mutations. In particular, our cohort highlights the predom-
inant role of MSH2 (11 cases) mutations compared to
MLH1 (2 cases) in the pathogenesis of MTS phenotype
(Table 2).
FGs and/or sebaceous hyperplasia present in the oral
mucosa may be a clinical marker associated with MTS and
represent a clinical stigmata of the syndromic heredofamilial
spectrum. The relatively low frequency of FGs in the
general population supports the potential use of such lesions
in the identiﬁcation of MTS, as well as in the recognition of
potential gene carriers of germ line mutation within speciﬁc
families that can be selectively addressed to genetic
screening.
RCM is a non-invasive diagnostic tool that allows us to
characterize FGs from the diagnostic point of view without
the need of a biopsy; in particular, it provides a quantitative
and qualitative assessment of glandular acini of the mucosa
and the collection of speciﬁc image patterns of gland
hyperplasia.
Future studies on larger populations carrying MMR gene
mutations are needed to clarify the predictive value of FGs
in the detection of MTS and HNPCC.
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